Cleveland Clinic account plan
Medical research and care
At a glance
Cleveland Clinic is a nonprofit academic health system with 21 hospitals and 83,000 caregivers; FY2025 total unrestricted revenue was $18.3 billion.
The Cleveland Clinic Foundation is a nonprofit, tax-exempt Ohio corporation providing medical and hospital care, research and education; with its affiliates it operates as the Cleveland Clinic Health System. At 31 December 2025 it ran 21 hospitals with about 5,500 staffed beds and 303 outpatient facilities in Northeast Ohio (15 hospitals), Southeast Florida (5 hospitals) and London (1 hospital), plus sites in Toronto and Las Vegas and management of Cleveland Clinic Abu Dhabi. In FY2025 total unrestricted revenue was $18.3 billion (+14.7%), operating income $913 million (5.0% operating margin) and excess of revenues over expenses $2.3 billion. It employs 83,000 caregivers worldwide and is the largest employer in Ohio. Medicare is 37% of net patient service revenue, Medicaid 10% and managed care and commercial 52%.
Business units
Northeast Ohio market
15 hospitals; main campus 1,273 staffed bedsThe largest market, anchored by the main campus, with Fairview, Hillcrest, Akron General and other hospitals, 22 outpatient family health centers and nine ambulatory surgery centers. In 2025 acute admissions in Ohio rose 2.5% and surgical cases 2.1%. Jorge Guzman, MD, led the market and became Executive Vice President of the U.S. Markets from 1 April 2026.
Florida market
5 hospitals; 40 outpatient locationsWeston Hospital, Martin North, Martin South, Tradition and Indian River in Southeast Florida, under a separate Florida Board and Conor Delaney, MD, President of the Florida Market. In 2025 acute admissions fell 2.8% while surgical cases rose 4.8%; a new hospital of about 200 inpatient beds is planned in West Palm Beach once initial fundraising goals are met.
Cleveland Clinic London
184 bedsLondon Hospital and two outpatient facilities in central London, focused on cardiovascular, digestive, neurological and orthopedic care; about 150,000 patient encounters in 2025 (+13.5%). An 81,000 square foot cancer centre is under construction for completion by end 2027, and Beri Ridgeway, MD, becomes President on 1 June 2026.
Other international and specialty sites
management service agreement revenue $209.2 million in 2025A Toronto health and wellness center, a neurological clinical center in Las Vegas, management of Cleveland Clinic Abu Dhabi (364 staffed beds), and the Cleveland Clinic Connected affiliation program with members in Vietnam, Uzbekistan, Zagreb and the US.
Value-based care (Medicare Advantage delegated risk)
premium revenue $616.7 million in 2025Delegated premium and risk agreements with national payors, run through the Quality Alliance clinically integrated network; a third agreement took effect on 1 January 2026 and premium revenue rose 32.9% in H1 2026.
Research, education and Cleveland Clinic Innovations
research support $444.9 million in 2025External grants of $347.2 million in 2025, two new research buildings in the Cleveland Innovation District, and an Innovations arm with over 950 technology licenses, over 2,850 patents and 108 spin-offs since 2000. Partners include IBM, Canon and Miami University.
Strategic priorities
- AI across care and operations
- The CEO's plan is to use AI to integrate staffing, scheduling, supply chain and patient care in real time and to build a global primary care delivery platform; he expects most primary care to be delivered through AI eventually.
- One standardised operating model
- Five years of restructuring standardised clinical service lines, digital infrastructure and data across 370 service sites on three continents, under the enterprise, market-focused operating model adopted in 2024.
- Safety, quality and patient experience in 2026
- The 2026 focus is safety, quality and patient experience, with work on documentation, medication safety and preventing harm, under four focus areas: Transform Care, Empower Caregivers, Uplift Communities and Sustain Cleveland Clinic.
- Growth across regions and specialties
- The growth agenda includes the Neurological Building (first patient January 2027), a Level One Trauma Center pursuit, the Fairview cancer centre, the Avon expansion, a West Palm Beach hospital, the London cancer centre (end 2027) and international opportunities from Vietnam and Uzbekistan to the Middle East and South America.
- Neuroscience
- The CEO calls neurological disease the next major frontier; the Neurological Institute building of about one million square feet opens in Q1 2027.
- Cost reduction and efficiency
- Management continues cost reduction and efficiency initiatives to capture synergies across its global enterprise and build a scalable cost structure aligned with patient volumes.
Latest results
In the six months to 30 June 2026 total unrestricted revenue rose 10.3% to $9,654 million from $8,750 million, operating income rose 35.8% to $418.4 million (4.3% margin vs 3.5%) and operating cash flow was $870 million (9.0% margin). In Q2 2026 revenue rose 8.7% to $4,930 million, but operating income fell to $245.6 million (5.0% margin vs 5.6%) as operating expenses grew 9.5%. Growth came from volume (total encounters +2.1%, surgical cases +2.7% in the half), managed care rates, state directed payment programs and a third Medicare Advantage risk agreement. Cash and investments reached $18.3 billion, or 337 days cash on hand, and debt was $6.4 billion. The documents give no numeric guidance.
Investments and deals
- Capital programme
- Property, plant and equipment spending was $1,150 million in 2025 and $546.5 million in H1 2026, with construction commitments of $614.4 million at end 2025.
- Neurological Institute building
- A building of about one million square feet opening in Q1 2027, which the CEO describes as the largest dedicated hospital facility focused solely on neurological disease.
- Research buildings and London cancer centre
- Two research buildings (about 296,000 square feet) in the Cleveland Innovation District and an 81,000 square foot London cancer centre started November 2025 for completion by end 2027; Fairview and Avon expansions run to 2027 and 2029.
- Series 2026 bonds and commercial paper
- In March 2026 the State of Ohio issued $552.6 million Series 2026A bonds (over $600 million of proceeds for capital spending) and $131.1 million Series 2026B refunding bonds; a new taxable commercial paper programme of up to $250 million was set up.
- Technology partnerships
- Partnerships with IBM (quantum), Amazon One Medical, Canon and Regent Surgical, AI partners named as Palantir, IBM and Oracle, and a sepsis detection tool with Bayesian Health rolled out across US and Florida hospitals.
Challenges and risks
- Federal reimbursement and funding changes
- Risks named include Medicare and Medicaid reimbursement and eligibility changes, the One Big Beautiful Bill Act, the 340B program and reductions in research and education funding.
- Cost inflation
- In H1 2026 insurance rose 53.9% on malpractice settlements, purchased services 24.1% and pharmaceuticals 12.9%; in Q2 2026 expenses grew 9.5% against 8.7% revenue growth.
- Florida integration and competition
- Moody's cites ongoing integration and improvement strategies in Florida and heavy competition; Florida acute admissions fell 2.8% in 2025.
- Cyber threats
- The financial statements list cyber threats and cyber insurance costs as risks, and the CEO warns that a fragmented digital landscape makes healthcare an attractive target as AI lowers the barrier for attackers.
- Demographics and leverage
- Unfavourable demographic trends in Greater Cleveland, and S&P flags slightly elevated leverage metrics and a robust capital spending programme.
What leadership says
“for healthcare to prosper, the way it is structured needs to be different.”
“I think a lot of pre-work needs to be put in place in order to really harvest the potential of artificial intelligence in health care.”
“The standalone hospitals of the past are not the greatest vehicle to deliver 21st-century healthcare.”
“We came to the realization that neurological disease is the next major frontier.”
Where a supplier can help
- Enterprise AI on a standardised platform
- Tied to the AI priority and the standardised operating model: AI for staffing, scheduling, supply chain and documentation that can roll out across all sites at once rather than one hospital at a time.
- Cybersecurity
- Tied to the cyber threats challenge: security services and tooling for a system the CEO describes as an attractive target as AI lowers the barrier for attackers.
- Construction fit-out and equipment
- Tied to the capital programme: equipment, fit-out and building systems for the Neurological Institute, the research buildings, the London cancer centre and the Fairview and Avon expansions.
- Cost and supply efficiency
- Tied to cost inflation and the cost reduction initiatives: purchasing, pharmacy, supplies and purchased-services savings that help a scalable cost structure.
- Value-based care and primary care tools
- Tied to the Medicare Advantage risk agreements and the plan to rebuild primary care with AI at its centre: care management and remote chronic care tools.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Cleveland Clinic?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Cleveland Clinic Health System Consolidated Financial Statements and Other Information for the period ended December 31, 2025 (with Management Discussion and Analysis)
- Cleveland Clinic Health System is a nonprofit, tax-exempt Ohio academic medical system: 21 hospitals, about 5,500 staffed beds and 303 outpatient facilities at 31 December 2025, in Northeast Ohio (15 hospitals), Southeast Florida (5 hospitals), London (1 hospital), plus Toronto, Las Vegas and management of Cleveland Clinic Abu Dhabi.
- FY2025 total unrestricted revenue of $18.3 billion (+14.7%), operating income of $913 million (5.0% operating margin, vs 1.7% in 2024) and operating cash flow of $1.8 billion (9.6% margin); excess of revenues over expenses of $2.3 billion (11.7% total margin).
- Growth drivers: net patient service revenue +$1.3 billion, higher case mix, managed care rate increases, $616.7 million of new Medicare Advantage delegated premium revenue (two value-based risk agreements effective 1 January 2025), and outpatient retail and specialty pharmacy (+$345.2 million).
- Payor mix of net patient service revenue: Medicare 37%, Medicaid 10%, managed care and commercial 52%, self-pay 1%; 14.7 million total patient encounters (+1.7%) and 335,613 surgical cases (+3.0%).
- Strong balance sheet: $16.8 billion of cash and investments, 323 days cash on hand, 12.8% investment return in 2025; debt of $5.9 billion; Aa2 (Moody's) and AA (S&P) ratings affirmed in March 2026; $552.6 million Series 2026A bonds issued in March 2026.
- Heavy capital programme: $1,150 million of property, plant and equipment spending in 2025; a one million square-foot Neurological Institute building opening in Q1 2027, two research buildings in the Cleveland Innovation District, a London cancer centre, Avon and Fairview expansions and a planned ~200-bed West Palm Beach hospital.
- Strategy built on four care priorities (patients, caregivers, organization, community) and four focus areas (Transform Care, Empower Caregivers, Uplift Communities, Sustain Cleveland Clinic) under an enterprise, market-focused operating model adopted in 2024; technology partnerships with IBM (quantum), Amazon One Medical, Canon, Regent Surgical.
- Main risks named: Medicare/Medicaid and federal funding changes (One Big Beautiful Bill Act, 340B), payer negotiations, competition, Florida integration, cyber threats, malpractice inflation (insurance expense +22.9%), unfavourable Greater Cleveland demographics.
- Cleveland Clinic Health System Consolidated Financial Statements and Other Information for the period ended June 30, 2026
- H1 2026 (six months to 30 June 2026): total unrestricted revenue $9.7 billion (+10.3%), operating income $418 million (4.3% margin vs 3.5%), operating cash flow $870 million (9.0% margin); excess of revenues over expenses $1.2 billion (11.1% total margin).
- Q2 2026: revenue $4.9 billion (+8.7%), operating income $246 million (5.0% margin vs 5.6% a year earlier, -3.7%), as expenses grew 9.5% against revenue growth of 8.7%.
- Volumes up: total patient encounters +2.1% in H1, surgical cases +2.7%, outpatient evaluation and management visits +2.7%, emergency visits -2.0%.
- Revenue drivers: managed care rate increases, a new Ohio physician state directed payment program approved by CMS in Q1 2026, expanded Ohio and Florida hospital programs, outpatient specialty pharmacy, and a third Medicare Advantage delegated risk agreement effective 1 January 2026 (premium revenue +32.9% in H1).
- Cost pressure: personnel cost growth held to 4.9% (FTEs +1.5% in H1), pharmaceuticals +12.9%, insurance +53.9% on malpractice settlements, purchased services +24.1% (franchise fees and directed payment program costs).
- Balance sheet: cash and investments $18.3 billion, 337 days cash on hand, debt $6.4 billion after the March 2026 Series 2026A ($552.6 million) and 2026B ($131.1 million) bonds; new $250 million taxable commercial paper programme.
- Capital spending of $546.5 million on property, plant and equipment in the first half; 21 hospitals and 5,459 staffed beds at 30 June 2026.
- State of the Clinic: Cleveland Clinic Meets Healthcare Challenges with Innovative Solutions
- Annual State of the Clinic address by CEO and President Tom Mihaljevic, MD, on 26 January 2026, reported by Cleveland Clinic's newsroom.
- 2025: nearly 16 million patient encounters, $18 billion of operating revenue and an operating margin exceeding 4%; 83,000 caregivers worldwide.
- Core message: "Cleveland Clinic is a model of what healthcare could become", but "for healthcare to prosper, the way it is structured needs to be different."
- AI at the centre: integrating staffing, scheduling, supply chain and patient care in real time, and building a global primary care delivery platform.
- New values: "Serve with heart. Succeed as one team. Shape the future."; 2026 focus on safety, quality and patient experience (documentation, medication safety, preventing harm).
- Growth agenda: Neurological Building first patient January 2027, Innovation District completion, Level One Trauma Center pursuit, Fairview cancer centre, Avon expansion, West Palm Beach hospital fundraising, London cancer centre (end 2027), Global Peak Performance Center (August 2027).
- Largest research investment in its history, doubling capacity; $1.49 billion committed to research, education and community programs.
- Cleveland Clinic CEO: AI Can't Work Without Fixing the System First (Newsweek AI Agenda webinar)
- Tom Mihaljevic, MD, CEO and President, in conversation with Harvard Business School professor Suraj Srinivasan in Newsweek's "AI Agenda" webinar on 27 April 2026, reported by Newsweek.
- AI is not "magical dust": "a lot of pre-work needs to be put in place in order to really harvest the potential of artificial intelligence in health care."
- The biggest problem: a model offering exceptional, timely care to all at affordable prices "currently does not exist"; AI can help solve it.
- Five years of "deep" restructuring standardised service lines, digital infrastructure and data across 370 service sites on three continents: "we really function as one unit".
- Digital, AI and data chiefs hired from outside healthcare, on Craig Mundie's advice that a healthcare background "should be a disqualifier"; partners include Palantir, IBM and Oracle.
- Fragmentation (more than 5.5 thousand US hospitals, many small and under-capitalised) limits AI's impact and raises cyber risk; AI is "geography agnostic" and can democratise exceptional care.
- Expects "most primary care will be delivered through AI", rebuilt with AI "in the center of the future system".
- Dr. Tomislav Mihaljevic, Cleveland Clinic (Investment Reports interview)
- Written interview of Dr. Tomislav (Tom) Mihaljevic, CEO and President, published by Investment Reports on 2 July 2026.
- Healthcare delivery must evolve: "The standalone hospitals of the past are not the greatest vehicle to deliver 21st-century healthcare"; large integrated systems are needed.
- AI impact across clinical care, caregivers (automating administrative burden), operations and research; sepsis detection with Bayesian Health rolled out across US and Florida hospitals.
- International expansion aims to bring Cleveland Clinic standards to more patients; opportunities from Vietnam and Uzbekistan to the Middle East and South America; Abu Dhabi has dozens of residency and fellowship programmes after ten years.
- Complex cancer cases are decided by consensus of experts across the whole network so quality is identical across locations.
- Future hospitals: "fewer hospitals, they will be larger in size, they will care for much sicker patients", part of larger systems, with chronic care moving to outpatient and home.
- Neuroscience is "the next major frontier"; Cleveland Clinic is about to open what it believes is the largest dedicated neurological hospital facility.
Questions about Cleveland Clinic
What does Cleveland Clinic do?
Cleveland Clinic is a nonprofit academic health system providing hospital and medical care, research and education, with 21 hospitals and 303 outpatient facilities in Ohio, Florida and London, plus sites in Toronto, Las Vegas and Abu Dhabi.
What was Cleveland Clinic's revenue in 2025?
FY2025 total unrestricted revenue was $18.3 billion, up 14.7%, with operating income of $913 million (5.0% margin). In H1 2026 revenue was $9,654 million, up 10.3%.
How many employees does Cleveland Clinic have?
Cleveland Clinic employs 83,000 caregivers worldwide and is the largest employer in Ohio.
Who leads Cleveland Clinic?
Tom (Tomislav) Mihaljevic, MD, is CEO and President. Jorge Guzman, MD, is Executive Vice President of the U.S. Markets from 1 April 2026.
What is Cleveland Clinic's strategy?
It runs four focus areas (Transform Care, Empower Caregivers, Uplift Communities, Sustain Cleveland Clinic) under one enterprise operating model, with AI at the centre of care and operations, growth across regions and specialties, and neuroscience as its next major frontier.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)